메뉴 건너뛰기




Volumn 2018, Issue 3, 2018, Pages

Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; METHYLPREDNISOLONE; PREDNISOLONE; GLUCOCORTICOID;

EID: 84973555942     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD006897.pub4     Document Type: Review
Times cited : (15)

References (93)
  • 1
    • 85041748610 scopus 로고    scopus 로고
    • The efficacy and treatment length of oral corticosteroids in patients with acute exacerbations of chronic obstructive pulmonary disease [Abstract]
    • 2923538
    • Chen G, Xie C. The efficacy and treatment length of oral corticosteroids in patients with acute exacerbations of chronic obstructive pulmonary disease [Abstract]. European Respiratory Journal 2005;26(Suppl 49):Abstract No. 1966. 2923538
    • (2005) European Respiratory Journal , vol.26
    • Chen, G.1    Xie, C.2
  • 2
    • 77956284324 scopus 로고    scopus 로고
    • [The effects and therapeutic duration of oral corticosteroids in patients with acute exacerbation of chronic obstructive pulmonary diseases]. [Chinese]
    • 2923539
    • Chen G, Xie CM, Luo YF. [The effects and therapeutic duration of oral corticosteroids in patients with acute exacerbation of chronic obstructive pulmonary diseases]. [Chinese]. Chinese Journal of Tuberculosis and Respiratory Diseases [Chung-Hua Chieh Ho Ho Hu Hsi Tsa Chih] 2008;31(8):577-80. 2923539
    • (2008) Chinese Journal of Tuberculosis and Respiratory Diseases [Chung-Hua Chieh Ho Ho Hu Hsi Tsa Chih] , vol.31 , Issue.8 , pp. 577-580
    • Chen, G.1    Xie, C.M.2    Luo, Y.F.3
  • 3
    • 85041722661 scopus 로고    scopus 로고
    • Duration of systemic corticosteroids treatment in COPD exacerbations [Abstract]
    • European Respiratory Society 18th Annual Congress; 2008 Oct 3-7; Berlin. :. 2923541
    • Gomaa M, Faramawy M, Ibrahim H. Duration of systemic corticosteroids treatment in COPD exacerbations [Abstract]. European Respiratory Society 18th Annual Congress; 2008 Oct 3-7; Berlin. 2008:[P3601]. 2923541
    • (2008) , pp. P3601
    • Gomaa, M.1    Faramawy, M.2    Ibrahim, H.3
  • 4
    • 84878538257 scopus 로고    scopus 로고
    • Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial
    • 7743984
    • Leuppi JD, Schuetz P, Bingisser R, Bodmer M, Briel M, Drescher, et al. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA 2013;309(21):2223-31. 7743984
    • (2013) JAMA , vol.309 , Issue.21 , pp. 2223-2231
    • Leuppi, J.D.1    Schuetz, P.2    Bingisser, R.3    Bodmer, M.4    Briel, M.5    Drescher6
  • 6
    • 79952196700 scopus 로고    scopus 로고
    • Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease-the "REDUCE" trial
    • 2923544
    • Schuetz P, Leuppi JD, Tamm M, Briel M, Bingisser R, Dürring U, et al. Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease-the "REDUCE" trial. Swiss Medical Weekly 2011;140(18 October 2010):w13109. 2923544
    • (2011) Swiss Medical Weekly , vol.140 , Issue.18 OCTOBER 2010
    • Schuetz, P.1    Leuppi, J.D.2    Tamm, M.3    Briel, M.4    Bingisser, R.5    Dürring, U.6
  • 7
    • 85041707050 scopus 로고    scopus 로고
    • Role of 7-day and 14-day courses of oral prednisolone treatment in acute exacerbation of COPD [Abstract]
    • 2923546
    • Abdullah Al Mamun SM, Rahman S. Role of 7-day and 14-day courses of oral prednisolone treatment in acute exacerbation of COPD [Abstract]. Thorax 2011;66(Suppl 4):A172. 2923546
    • (2011) Thorax , vol.66 , pp. A172
    • Abdullah Al Mamun, S.M.1    Rahman, S.2
  • 8
    • 70349097580 scopus 로고    scopus 로고
    • Role of 7-day and 14-day courses of oral prednisolone treatment in acute exacerbation of COPD [Abstract]
    • 2923547
    • Rahman M, Abdullah A, Mamun SM, Haque MD. Role of 7-day and 14-day courses of oral prednisolone treatment in acute exacerbation of COPD [Abstract]. Chest 2004;126(4 Suppl):839S-a. 2923547
    • (2004) Chest , vol.126 , Issue.4 , pp. 839S-839a
    • Rahman, M.1    Abdullah, A.2    Mamun, S.M.3    Haque, M.D.4
  • 10
    • 0035089716 scopus 로고    scopus 로고
    • Systemic glucocorticoids in severe exacerbations of COPD
    • 2923551
    • Sayiner A, Aytemur ZA, Cirit M, Unsal I. Systemic glucocorticoids in severe exacerbations of COPD. Chest 2001;119(3):726-30. 2923551
    • (2001) Chest , vol.119 , Issue.3 , pp. 726-730
    • Sayiner, A.1    Aytemur, Z.A.2    Cirit, M.3    Unsal, I.4
  • 11
    • 85028579849 scopus 로고    scopus 로고
    • Comparison between 5 days and 10 days of prednisolone in treatment of acute exacerbation of chronic obstructive pulmonary disease [Abstract]
    • 2923553 [012-A120 [01]
    • Sirichana W, Sittipunt C, Kawkitinarong K, Wongtim S. Comparison between 5 days and 10 days of prednisolone in treatment of acute exacerbation of chronic obstructive pulmonary disease [Abstract]. Respirology 2008;13(Suppl 5):A120 [012-01]. 2923553
    • (2008) Respirology , vol.13 , pp. A120
    • Sirichana, W.1    Sittipunt, C.2    Kawkitinarong, K.3    Wongtim, S.4
  • 12
    • 0000221517 scopus 로고    scopus 로고
    • A double-blind, randomised, placebo-controlled trial of corticosteroids for acute exacerbations of chronic obstructive pulmonary disease [Abstract]
    • 2923555
    • Wood-Baker R, Wilkinson J, Pearce M, Ryan G. A double-blind, randomised, placebo-controlled trial of corticosteroids for acute exacerbations of chronic obstructive pulmonary disease [Abstract]. Australian & New Zealand Journal of Medicine 1998;28:262. 2923555
    • (1998) Australian & New Zealand Journal of Medicine , vol.28 , pp. 262
    • Wood-Baker, R.1    Wilkinson, J.2    Pearce, M.3    Ryan, G.4
  • 13
    • 0037832413 scopus 로고    scopus 로고
    • Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease [comment]
    • 2923557
    • Aaron SD, Vandemheen KL, Hebert P, Dales R, Stiell IG, Ahuja J, et al. Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease [comment]. New England Journal of Medicine 2003;348(26):2618-25. 2923557
    • (2003) New England Journal of Medicine , vol.348 , Issue.26 , pp. 2618-2625
    • Aaron, S.D.1    Vandemheen, K.L.2    Hebert, P.3    Dales, R.4    Stiell, I.G.5    Ahuja, J.6
  • 15
    • 0018825423 scopus 로고
    • Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency
    • 2923559
    • Albert RK, Martin TR, Lewis SW. Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency. Annals of Internal Medicine 1980;92(6):753-8. 2923559
    • (1980) Annals of Internal Medicine , vol.92 , Issue.6 , pp. 753-758
    • Albert, R.K.1    Martin, T.R.2    Lewis, S.W.3
  • 16
    • 44849084468 scopus 로고    scopus 로고
    • A PEACE-ful solution to COPD exacerbations? [comment]
    • 2923561
    • Albert P, Calverley P. A PEACE-ful solution to COPD exacerbations? [comment]. Lancet 2008;371(9629):1975-6. 2923561
    • (2008) Lancet , vol.371 , Issue.9629 , pp. 1975-1976
    • Albert, P.1    Calverley, P.2
  • 17
    • 85044101418 scopus 로고    scopus 로고
    • Methyl prednisolone vs dexamethasone in management of COPD exacerbation; a randomized clinical trial
    • 7743989
    • Ardestani E, Kalantary E, Samaiy, Taherian K. Methyl prednisolone vs dexamethasone in management of COPD exacerbation; a randomized clinical trial. Emergency 2017;5(1):195-200. 7743989
    • (2017) Emergency , vol.5 , Issue.1 , pp. 195-200
    • Ardestani, E.1    Kalantary, E.2    Samaiy3    Taherian, K.4
  • 19
    • 84895921015 scopus 로고    scopus 로고
    • Comparison of two systemic steroid regimens for the treatment of COPD exacerbations
    • 7743993
    • Ceviker Y, Sayiner A. Comparison of two systemic steroid regimens for the treatment of COPD exacerbations. Pulm Pharmacol Ther Apr 2014;27(2):179-83. 7743993
    • (2014) Pulm Pharmacol Ther Apr , vol.27 , Issue.2 , pp. 179-183
    • Ceviker, Y.1    Sayiner, A.2
  • 22
    • 0141885151 scopus 로고    scopus 로고
    • Oral prednisone prevents relapse in COPD exacerbations
    • 2923566
    • Courtney AU. Oral prednisone prevents relapse in COPD exacerbations. Journal of Family Practice 2003;52(10):762-4. 2923566
    • (2003) Journal of Family Practice , vol.52 , Issue.10 , pp. 762-764
    • Courtney, A.U.1
  • 23
    • 4243745857 scopus 로고    scopus 로고
    • A prospective, randomised, double-blind, placebo controlled study of oral corticosteroids in patients admitted with normocapnic acute exacerbations of chronic obstructive pulmonary disease (COPD)
    • 2923568
    • Davies L, Angus R, Mand Calverley PMA. A prospective, randomised, double-blind, placebo controlled study of oral corticosteroids in patients admitted with normocapnic acute exacerbations of chronic obstructive pulmonary disease (COPD). Thorax 1997;52(Suppl 6):A5 S18. 2923568
    • (1997) Thorax , vol.52 , pp. A5 S18
    • Davies, L.1    Angus, R.2    Mand Calverley, P.M.A.3
  • 24
    • 0033533144 scopus 로고    scopus 로고
    • Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial
    • 2923569
    • Davies L, Angus RM, Calverley PM. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Lancet 1999;354(9177):456-60. 2923569
    • (1999) Lancet , vol.354 , Issue.9177 , pp. 456-460
    • Davies, L.1    Angus, R.M.2    Calverley, P.M.3
  • 25
    • 33745929178 scopus 로고    scopus 로고
    • A comparison of intravenous versus oral administration of corticosteroids in the treatment of patients admitted to the hospital with an exacerbation of COPD [Abstract]
    • 2923571
    • De Jong YP, Uil M, Grotjohan P, Postma S, Kerstjens M, Van den Berg JWK. A comparison of intravenous versus oral administration of corticosteroids in the treatment of patients admitted to the hospital with an exacerbation of COPD [Abstract]. European Respiratory Journal 2004;24(Suppl 48):64s. 2923571
    • (2004) European Respiratory Journal , vol.24 , pp. 64s
    • De Jong, Y.P.1    Uil, M.2    Grotjohan, P.3    Postma, S.4    Kerstjens, M.5    Van den Berg, J.W.K.6
  • 26
    • 37549054671 scopus 로고    scopus 로고
    • Oral or IV prednisolone in the treatment of COPD exacerbations: a randomized, controlled, double-blind study.[see comment]. Comment in: Chest. 2007 Dec;132(6):1728-9; PMID: 18079214
    • 2923572
    • De Jong YP, Uil SM, Grotjohan HP, Postma DS, Kerstjens HA, Van den Berg JW. Oral or IV prednisolone in the treatment of COPD exacerbations: a randomized, controlled, double-blind study.[see comment]. Comment in: Chest. 2007 Dec;132(6):1728-9; PMID: 18079214. Chest 2007;132(6):1741-7. 2923572
    • (2007) Chest , vol.132 , Issue.6 , pp. 1741-1747
    • De Jong, Y.P.1    Uil, S.M.2    Grotjohan, H.P.3    Postma, D.S.4    Kerstjens, H.A.5    Van den Berg, J.W.6
  • 28
    • 85041737572 scopus 로고    scopus 로고
    • A single centre, randomised, double-blind, parallel group study to compare the efficacy of nebulised fluticasone propionate 2 mg twice daily (bd) with placebo in patients with moderate to severe chronic obstructive pulmonary disease
    • 2923574
    • GlaxoSmithKline. A single centre, randomised, double-blind, parallel group study to compare the efficacy of nebulised fluticasone propionate 2 mg twice daily (bd) with placebo in patients with moderate to severe chronic obstructive pulmonary disease. GlaxoSmithKline Clinical Trial Register 2005. 2923574
    • (2005) GlaxoSmithKline Clinical Trial Register
  • 29
    • 85044133389 scopus 로고    scopus 로고
    • A prospective study for evaluating the clinical efficacy of methylxanthines in patients of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) admitted in a tertiary care hospital
    • 7743997
    • Kalkoti V, Kanani NJ. A prospective study for evaluating the clinical efficacy of methylxanthines in patients of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) admitted in a tertiary care hospital. Indian journal of pharmacology 2014;46(7 SUPPL. 1):S25. 7743997
    • (2014) Indian journal of pharmacology , vol.46 , Issue.7 , pp. S25
    • Kalkoti, V.1    Kanani, N.J.2
  • 30
    • 0038271786 scopus 로고    scopus 로고
    • A step-wise application of methylprednisolone versus dexamethasone in the treatment of acute exacerbations of COPD
    • 2923576
    • Li H, He G, Chu H, Zhao L, Yu H. A step-wise application of methylprednisolone versus dexamethasone in the treatment of acute exacerbations of COPD. Respirology 2003;8(2):199-204. 2923576
    • (2003) Respirology , vol.8 , Issue.2 , pp. 199-204
    • Li, H.1    He, G.2    Chu, H.3    Zhao, L.4    Yu, H.5
  • 31
    • 85041722793 scopus 로고    scopus 로고
    • The application of methylprednisolone in acute exacerbations of COPD
    • 2923577
    • Li HP, He GJ, Chu HQ. The application of methylprednisolone in acute exacerbations of COPD. European Respiratory Journal 2000;16(Suppl 31):50s. 2923577
    • (2000) European Respiratory Journal , vol.16 , pp. 50s
    • Li, H.P.1    He, G.J.2    Chu, H.Q.3
  • 32
    • 84974679286 scopus 로고    scopus 로고
    • Nebulized budesonide in the treatment of exacerbations of chronic obstructive pulmonary disease: Efficacy, safety, and effects on the serum levels of soluble differentiation molecules
    • 7743999
    • Makarova EV, Varvarina GN, Menkov NV, Tsapaeva MY, Lazareva ES, Kazatskaya ZhA, Novikov VV, Karaulov AV. Nebulized budesonide in the treatment of exacerbations of chronic obstructive pulmonary disease: Efficacy, safety, and effects on the serum levels of soluble differentiation molecules. Terapevticheskii arkhi 2016;88(3):24-31. 7743999
    • (2016) Terapevticheskii arkhi , vol.88 , Issue.3 , pp. 24-31
    • Makarova, E.V.1    Varvarina, G.N.2    Menkov, N.V.3    Tsapaeva, M.Y.4    Lazareva, E.S.5    Kazatskaya, Z.6    Novikov, V.V.7    Karaulov, A.V.8
  • 33
    • 0033981598 scopus 로고    scopus 로고
    • The results of a randomized controlled trial of hydrocortisone in acute exacerbation of COPD
    • 2923579
    • McCrory DC, Hasselblad V. The results of a randomized controlled trial of hydrocortisone in acute exacerbation of COPD. American Journal of Emergency Medicine 2000;18(1):122. 2923579
    • (2000) American Journal of Emergency Medicine , vol.18 , Issue.1 , pp. 122
    • McCrory, D.C.1    Hasselblad, V.2
  • 34
    • 85044163988 scopus 로고    scopus 로고
    • Efficacy of different regimens of steroid therapy in patients with exacerbation of chronic obstructive pulmonary disease
    • 7744001
    • Odonchimeg P, Ichinnorov D, Sarantuyaa Zh, Tumur-Ochir Ts, Choyzhamts G. Efficacy of different regimens of steroid therapy in patients with exacerbation of chronic obstructive pulmonary disease. Pulmonologiya 2015;25(1):58-63. 7744001
    • (2015) Pulmonologiya , vol.25 , Issue.1 , pp. 58-63
    • Odonchimeg, P.1    Ichinnorov, D.2    Sarantuyaa, Z.3    Tumur-Ochir, T.4    Choyzhamts, G.5
  • 35
    • 84925354175 scopus 로고    scopus 로고
    • Protocol-based treatment of septic shock, fibrinolysis for submassive pulmonary embolism, and use of corticosteroids in acute exacerbations of chronic obstructive pulmonary disease requiring mechanical ventilation
    • 7744003
    • Sharma N, Venado A, Morrison J. Protocol-based treatment of septic shock, fibrinolysis for submassive pulmonary embolism, and use of corticosteroids in acute exacerbations of chronic obstructive pulmonary disease requiring mechanical ventilation. Am J Respir Crit Care Med 2014;190(7):827-8. 7744003
    • (2014) Am J Respir Crit Care Med , vol.190 , Issue.7 , pp. 827-828
    • Sharma, N.1    Venado, A.2    Morrison, J.3
  • 36
    • 85044139993 scopus 로고    scopus 로고
    • Effect of low-dose glucocorticoid on corticosteroid insufficient patients with acute exacerbation of chronic obstructive pulmonary disease
    • 7744005
    • Sun WP, Yuan GX, Hu YJ, Liao LZ, Fu L. Effect of low-dose glucocorticoid on corticosteroid insufficient patients with acute exacerbation of chronic obstructive pulmonary disease. World Journal of Emergency Medicine 2015;6(1):34-39. 7744005
    • (2015) World Journal of Emergency Medicine , vol.6 , Issue.1 , pp. 34-39
    • Sun, W.P.1    Yuan, G.X.2    Hu, Y.J.3    Liao, L.Z.4    Fu, L.5
  • 37
    • 84926417891 scopus 로고    scopus 로고
    • Compare the efficacy of inhaled budesonide and systemic methylprednisolone on systemic inflammation of AECOPD
    • 7744007
    • Sun X, He Z, Zhang J, Deng J, Bai J, Li M, Zhong X. Compare the efficacy of inhaled budesonide and systemic methylprednisolone on systemic inflammation of AECOPD. Pulmonary pharmacology & therapeutics 2015;31:111-116. 7744007
    • (2015) Pulmonary pharmacology & therapeutics , vol.31 , pp. 111-116
    • Sun, X.1    He, Z.2    Zhang, J.3    Deng, J.4    Bai, J.5    Li, M.6    Zhong, X.7
  • 38
    • 84899863508 scopus 로고    scopus 로고
    • Corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease
    • 7744009
    • Woods JA, Wheeler JS, Finch CK, Pinner NA. Corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2014;9:421-30. 7744009
    • (2014) Int J Chron Obstruct Pulmon Dis , vol.9 , pp. 421-430
    • Woods, J.A.1    Wheeler, J.S.2    Finch, C.K.3    Pinner, N.A.4
  • 39
    • 84897446515 scopus 로고    scopus 로고
    • Two different dosages of nebulized steroid versus parenteral steroid in the management of COPD exacerbations: a randomized control trial
    • 7744011
    • Yilmazel Ucar E, Araz O, Meral M, Sonkaya E, Saglam L, Kaynar H, Gorguner AM, Akgun M. Two different dosages of nebulized steroid versus parenteral steroid in the management of COPD exacerbations: a randomized control trial. Med Sci Monit 2014;20:513-20. 7744011
    • (2014) Med Sci Monit , vol.20 , pp. 513-520
    • Yilmazel Ucar, E.1    Araz, O.2    Meral, M.3    Sonkaya, E.4    Saglam, L.5    Kaynar, H.6    Gorguner, A.M.7    Akgun, M.8
  • 40
    • 85044152354 scopus 로고    scopus 로고
    • Reduction of Corticosteroid Use in Outpatient Treatment of Exacerbated COPD (RECUT)
    • 7744013, NCT02386735
    • Leuppi J. Reduction of Corticosteroid Use in Outpatient Treatment of Exacerbated COPD (RECUT). Clinicaltrials.gov 2015:NCT02386735. 7744013
    • (2015) Clinicaltrials.gov
    • Leuppi, J.1
  • 45
    • 34548267728 scopus 로고    scopus 로고
    • International variation in the prevalence of COPD (the BOLD study): a population-based prevalence study
    • Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. International variation in the prevalence of COPD (the BOLD study): a population-based prevalence study. Lancet 2007;370(9589):741-50.
    • (2007) Lancet , vol.370 , Issue.9589 , pp. 741-750
    • Buist, A.S.1    McBurnie, M.A.2    Vollmer, W.M.3    Gillespie, S.4    Burney, P.5    Mannino, D.M.6
  • 48
    • 84890783342 scopus 로고    scopus 로고
    • Analysing data and undertaking meta-analyses
    • Higgins JPT, Green S editor(s). The Cochrane Collaboration Version 5.0.1 [updated September 2008]
    • Deeks JJ, Higgins JPT, Altman DG. Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. www.cochrane-handbook.org. The Cochrane Collaboration, 2008.
    • (2008) Cochrane Handbook for Systematic Reviews of Interventions
    • Deeks, J.J.1    Higgins, J.P.T.2    Altman, D.G.3
  • 50
    • 0036794862 scopus 로고    scopus 로고
    • Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease
    • Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002;57(10):847-52.
    • (2002) Thorax , vol.57 , Issue.10 , pp. 847-852
    • Donaldson, G.C.1    Seemungal, T.A.2    Bhowmik, A.3    Wedzicha, J.A.4
  • 52
    • 32644435902 scopus 로고    scopus 로고
    • COPD exacerbations 1: epidemiology
    • Donaldson GC, Wedzicha JA. COPD exacerbations 1: epidemiology. Thorax 2006;61:164-8.
    • (2006) Thorax , vol.61 , pp. 164-168
    • Donaldson, G.C.1    Wedzicha, J.A.2
  • 54
    • 0037062141 scopus 로고    scopus 로고
    • Azithromycin for acute bronchitis: a randomised, double-blind, controlled trial
    • Evans AT, Husain S, Durairaj L, Sadowski LS, Charles-Damte M, Wang Y. Azithromycin for acute bronchitis: a randomised, double-blind, controlled trial. Lancet 2002;359(9318):1648-54.
    • (2002) Lancet , vol.359 , Issue.9318 , pp. 1648-1654
    • Evans, A.T.1    Husain, S.2    Durairaj, L.3    Sadowski, L.S.4    Charles-Damte, M.5    Wang, Y.6
  • 56
    • 34147214922 scopus 로고    scopus 로고
    • Global Strategy for the Diagnosis, Management and Prevention of COPD
    • GOLD. Global Strategy for the Diagnosis, Management and Prevention of COPD, 2014. http://www.goldcopd.org/.
    • (2014)
  • 57
  • 60
    • 84887346660 scopus 로고    scopus 로고
    • Cochrane Handbook for Systematic Reviews of Interventions
    • Version 5.1.0 [updated March 2011]. The Cochrane Collaboration
    • Higgins J, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org.
    • (2011)
    • Higgins, J.1    Green, S.2
  • 62
    • 84921625539 scopus 로고    scopus 로고
    • Characterisation and impact of reported and unreported exacerbations: results from ATTAIN
    • 101183/0903193600038814
    • Jones PW, Lamarca R, Chuecos F, Singh D, Agusti A, Bateman ED, et al. Characterisation and impact of reported and unreported exacerbations: results from ATTAIN. European Respiratory Journal 2014;epub ahead of print:doi:10.1183/09031936.00038814.
    • (2014) European Respiratory Journal
    • Jones, P.W.1    Lamarca, R.2    Chuecos, F.3    Singh, D.4    Agusti, A.5    Bateman, E.D.6
  • 63
    • 84899881202 scopus 로고    scopus 로고
    • Outcomes associated with corticosteroid dosage in critically ill patients with acute exacerbations of chronic obstructive pulmonary disease
    • Kiser TH, Allen RR, Valuck RJ, Moss M, Vandivier RW. Outcomes associated with corticosteroid dosage in critically ill patients with acute exacerbations of chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2014;189(9):1052-64.
    • (2014) American Journal of Respiratory and Critical Care Medicine , vol.189 , Issue.9 , pp. 1052-1064
    • Kiser, T.H.1    Allen, R.R.2    Valuck, R.J.3    Moss, M.4    Vandivier, R.W.5
  • 64
    • 78650093203 scopus 로고    scopus 로고
    • Development of the EXAcerbations of chronic obstructive pulmonary disease Tool (EXACT): a patient-reported outcome (PRO) measure
    • Leidy NK, Wilcox TK, Jones PW, Murray L, Winnette R, Howard K, et al. Development of the EXAcerbations of chronic obstructive pulmonary disease Tool (EXACT): a patient-reported outcome (PRO) measure. Value in Health 2010;13(8):965-75.
    • (2010) Value in Health , vol.13 , Issue.8 , pp. 965-975
    • Leidy, N.K.1    Wilcox, T.K.2    Jones, P.W.3    Murray, L.4    Winnette, R.5    Howard, K.6
  • 66
    • 84898713016 scopus 로고    scopus 로고
    • Performance of the EXAcerbations of Chronic Pulmonary Disease Tool Patient-reported Outcome Measure in three clinical trials of chronic obstructive pulmonary disease
    • Leidy NK, Murray LT, Jones P, Sethi S. Performance of the EXAcerbations of Chronic Pulmonary Disease Tool Patient-reported Outcome Measure in three clinical trials of chronic obstructive pulmonary disease. Annals of the American Thoracic Society 2014;11(3):316-25.
    • (2014) Annals of the American Thoracic Society , vol.11 , Issue.3 , pp. 316-325
    • Leidy, N.K.1    Murray, L.T.2    Jones, P.3    Sethi, S.4
  • 67
    • 77953626306 scopus 로고    scopus 로고
    • Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease
    • Lindenauer PK, Pekow PS, Lahti MC, Lee Y, Benjamin EM, Rothberg MB. Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease. JAMA 2010;303(23):2359-67.
    • (2010) JAMA , vol.303 , Issue.23 , pp. 2359-2367
    • Lindenauer, P.K.1    Pekow, P.S.2    Lahti, M.C.3    Lee, Y.4    Benjamin, E.M.5    Rothberg, M.B.6
  • 69
    • 73749085209 scopus 로고    scopus 로고
    • Prevalence and predictors of vertebral fracture in patients with chronic obstructive pulmonary disease
    • Majumdar SR, Villa-Roel C, Lyons KJ, Rowe BH. Prevalence and predictors of vertebral fracture in patients with chronic obstructive pulmonary disease. Respiratory Medicine 2010;104(2):260-6.
    • (2010) Respiratory Medicine , vol.104 , Issue.2 , pp. 260-266
    • Majumdar, S.R.1    Villa-Roel, C.2    Lyons, K.J.3    Rowe, B.H.4
  • 70
    • 0030953914 scopus 로고    scopus 로고
    • Adverse effects of corticosteroid therapy for COPD
    • McEvoy CE, Niewoehner DE. Adverse effects of corticosteroid therapy for COPD. Chest 1997;111:732-43.
    • (1997) Chest , vol.111 , pp. 732-743
    • McEvoy, C.E.1    Niewoehner, D.E.2
  • 71
    • 0037451366 scopus 로고    scopus 로고
    • The COPDX Plan: Australian and New Zealand guidelines for the management of chronic obstructive pulmonary disease 2003
    • McKenzie DK, Frith PA, Burdon JG, Town GI. The COPDX Plan: Australian and New Zealand guidelines for the management of chronic obstructive pulmonary disease 2003. Medical Journal of Australia 2003;178(Suppl):S7-S39.
    • (2003) Medical Journal of Australia , vol.178 , pp. S7-S39
    • McKenzie, D.K.1    Frith, P.A.2    Burdon, J.G.3    Town, G.I.4
  • 72
    • 0031001720 scopus 로고    scopus 로고
    • Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study
    • Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 1997;349(9064):1498-504.
    • (1997) Lancet , vol.349 , Issue.9064 , pp. 1498-1504
    • Murray, C.J.1    Lopez, A.D.2
  • 73
    • 27844558361 scopus 로고    scopus 로고
    • Chronic obstructive pulmonary disease: national clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care [update 2010]
    • (accessed 18 July 2011)
    • National Institute for Health and Care Excellence. Chronic obstructive pulmonary disease: national clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care [update 2010]. http://guidance.nice.org.uk/CG101 (accessed 18 July 2011).
  • 74
    • 4043134574 scopus 로고    scopus 로고
    • Resource use and risk factors in high-cost exacerbations of COPD
    • Oostenbrink JB, Rutten-van Molken MP. Resource use and risk factors in high-cost exacerbations of COPD. Respiratory Medicine 2004;98:883-91.
    • (2004) Respiratory Medicine , vol.98 , pp. 883-891
    • Oostenbrink, J.B.1    Rutten-van Molken, M.P.2
  • 76
    • 84964921069 scopus 로고    scopus 로고
    • Review Manager (RevMan)
    • Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration
    • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
    • (2014)
  • 77
    • 0034064973 scopus 로고    scopus 로고
    • Toward a consensus definition for COPD exacerbations
    • Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest 2000;117(5 Suppl 2):398S-401S.
    • (2000) Chest , vol.117 , Issue.5 , pp. 398S-401S
    • Rodriguez-Roisin, R.1
  • 78
    • 70349146922 scopus 로고    scopus 로고
    • Exacerbations and associated health care cost in patients with chronic obstructive pulmonary disease in general practice. Results from the COOPT trial
    • Schermer T, Chavannes N, Saris C, Akkermans R, van Schayck C, van Weel C. Exacerbations and associated health care cost in patients with chronic obstructive pulmonary disease in general practice. Results from the COOPT trial. European Respiratory Journal 2002;20(Suppl 38):398s.
    • (2002) European Respiratory Journal , vol.20 , pp. 398s
    • Schermer, T.1    Chavannes, N.2    Saris, C.3    Akkermans, R.4    van Schayck, C.5    van Weel, C.6
  • 80
    • 0037103420 scopus 로고    scopus 로고
    • New strains of bacteria and exacerbations of chronic obstructive pulmonary disease
    • Sethi S, Evans N, Grant BJ, Murphy TF. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. New England Journal of Medicine 2002;347(7):465-71.
    • (2002) New England Journal of Medicine , vol.347 , Issue.7 , pp. 465-471
    • Sethi, S.1    Evans, N.2    Grant, B.J.3    Murphy, T.F.4
  • 81
    • 57149105188 scopus 로고    scopus 로고
    • Infection in the pathogenesis and course of chronic obstructive pulmonary disease
    • Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. New England Journal of Medicine 2008;359(22):2355-65.
    • (2008) New England Journal of Medicine , vol.359 , Issue.22 , pp. 2355-2365
    • Sethi, S.1    Murphy, T.F.2
  • 82
    • 0034525019 scopus 로고    scopus 로고
    • The chronic obstructive pulmonary disease exacerbation
    • Sherk PA, Grossman RF. The chronic obstructive pulmonary disease exacerbation. Clinics in Chest Medicine 2000;21(4):705-21.
    • (2000) Clinics in Chest Medicine , vol.21 , Issue.4 , pp. 705-721
    • Sherk, P.A.1    Grossman, R.F.2
  • 84
    • 84868209480 scopus 로고    scopus 로고
    • Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality
    • Suissa S, Dell'Aniello S, Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax 2012;67(11):957-63.
    • (2012) Thorax , vol.67 , Issue.11 , pp. 957-963
    • Suissa, S.1    Dell'Aniello, S.2    Ernst, P.3
  • 87
    • 36348969325 scopus 로고    scopus 로고
    • Fracture risk in patients with chronic lung diseases treated with bronchodilator drugs and inhaled and oral corticosteroids
    • PUBMED: 17890464 ]
    • Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk in patients with chronic lung diseases treated with bronchodilator drugs and inhaled and oral corticosteroids. Chest 2007;132(5):1599-607. [PUBMED: 17890464 ]
    • (2007) Chest , vol.132 , Issue.5 , pp. 1599-1607
    • Vestergaard, P.1    Rejnmark, L.2    Mosekilde, L.3
  • 88
    • 44949190506 scopus 로고    scopus 로고
    • Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease
    • Walters JA, Wang W, Morley C, Soltani A, Wood-Baker R. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2011, Issue 10. [DOI: 10.1002/14651858.CD006897.pub2]
    • (2011) Cochrane Database of Systematic Reviews , Issue.10
    • Walters, J.A.1    Wang, W.2    Morley, C.3    Soltani, A.4    Wood-Baker, R.5
  • 91
    • 0033940433 scopus 로고    scopus 로고
    • Oral corticosteroids for exacerbations of chronic obstructive pulmonary disease
    • Wedzicha JA. Oral corticosteroids for exacerbations of chronic obstructive pulmonary disease. Thorax 2000;55(Suppl 1):S23-7.
    • (2000) Thorax , vol.55 , pp. S23-S27
    • Wedzicha, J.A.1
  • 93
    • 0037372035 scopus 로고    scopus 로고
    • Economic analysis of the confronting COPD survey: an overview of results
    • Wouters EFM. Economic analysis of the confronting COPD survey: an overview of results. Respiratory Medicine 2003;97(Suppl 3):S3-S14.
    • (2003) Respiratory Medicine , vol.97 , pp. S3-S14
    • Wouters, E.F.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.